Stay updated on Nivolumab and Ipilimumab in ACC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in ACC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, signaling an updated version of the page's documentation or template. The change does not modify any study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-30T16:51:12.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed. This update is a metadata/version tag for the site and does not alter study content or user interactions.
    Difference
    0.0%
    Check dated 2026-04-16T10:49:23.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:51:04.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    - Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:51:29.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-lapse notice (previous Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T02:16:41.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Notice about government funding and NIH site operations added. The site version updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:36:38.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in ACC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.